Back to search

Article

Peri-Procedural Healthcare Costs of Thromboembolic and Bleeding Events in Patients on Direct Oral Anticoagulants Undergoing High-Risk Endoscopy

2026-08-03

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background and study aims</h4> Patients on direct oral anticoagulants (DOACs) undergoing high-risk endoscopy face competing risks of bleeding and thromboembolism during peri-procedural anticoagulant interruption. We quantified peri-procedural adverse event (AE) rates and incremental healthcare costs. <h4>Patients and methods</h4> Retrospective cohort study using the TriNetX Linked Claims d...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
22e4d2b6-4ddc-5e1f-9999-82c5ee11fbc2
DOI
10.64898/2026.07.31.26359377
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Peri-Procedural Healthcare Costs of Thromboembolic and Bleeding Events in Patients on Direct Oral Anticoagulants Undergoing High-Risk EndoscopyDOI 10.64898/2026.07.31.26359377
Management of antithrombotic agents during emergency endoscopy for upper gastrointestinal bleeding: A propensity score matching analysisSemantic proximity
Gastrointestinal Bleeding During Direct Oral Anticoagulants Therapy in Patients With Nonvalvular Atrial Fibrillation and Risk of PolypharmacySemantic proximity
Safety profile of rivaroxaban in first-time users treated for venous thromboembolism (deep vein thrombosis and pulmonary embolism) in four European countriesSemantic proximity
INCIDENCE OF VENOUS THROMBOTIC EVENTS AND EVENTS OF SPECIAL INTEREST IN A RETROSPECTIVE COHORT OF COMMERCIALLY-INSURED US PATIENTSSemantic proximity
Bleeding in cardiac patients prescribed antithrombotic drugs: Electronic health record phenotyping algorithms, incidence, trends and prognosisSemantic proximity
Re-starting anticoagulation and antiplatelets after gastrointestinal bleeding: A systematic reviewSemantic proximity
Effectiveness and Safety of Anticoagulants Among Patients with Venous Thromboembolism and Active Cancer Who Also Had Prior Bleed or Prior Renal DiseaseSemantic proximity
Prevalence and clinical implications of eligibility criteria for prolonged dual antithrombotic therapy in patients with PEGASUS and COMPASS phenotypes: Insights from the START-ANTIPLATELET registry.Semantic proximity
Utilization of Triple Antithrombotic Therapy in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary InterventionSemantic proximity
Contemporary burden of atrial fibrillation in mechanical thrombectomy stroke patients in the United StatesSemantic proximity
Long-Term Outcomes After Ischemic Stroke Across Atrial Fibrillation Phenotypes Defined by Detection Timing and Prior Anticoagulation Status.Semantic proximity
Ticagrelor versus clopidogrel in acute coronary syndrome patients with concurrent high ischemic and bleeding risk after drug-eluting stent implantationSemantic proximity
Select a neighboring publication to make it the new centre.